Data gathered: January 29
AI Stock Analysis - Teva Pharmaceutical (TEVA)
Analysis generated May 4, 2024. Powered by Chat GPT.
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that specializes in generic and specialty medicines, with a focus on neurological, respiratory, oncology, and autoimmune diseases among other therapeutic areas. Headquartered in Israel, Teva is one of the largest generic drug manufacturers in the world and has a complex portfolio of products and a strong pipeline of generic and specialty medications. The company is operating in a highly competitive and regulated market but has built a reputation for producing affordable and high-quality drugs.
Stock Alerts - Teva Pharmaceutical (TEVA)
 |
Teva Pharmaceutical | January 29 Price is down by -11.1% in the last 24h. |
|
Teva Pharmaceutical | January 15 Price is up by 5.1% in the last 24h. |
|
Teva Pharmaceutical | January 12 AI Score is down by 21.7% in the last couple of days. |
|
Teva Pharmaceutical | December 27 Insider Alert: MIGNONE ROBERTO is selling shares |
Alternative Data for Teva Pharmaceutical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 621 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 120,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 34 | Sign up | Sign up | Sign up |
| Facebook Followers | 54,797 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,479 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,684 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 8,240 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 74 | Sign up | Sign up | Sign up |
| Business Outlook | 62 | Sign up | Sign up | Sign up |
| Linkedin Employees | 28,445 | Sign up | Sign up | Sign up |
About Teva Pharmaceutical
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
| Price | $18.54 |
| Target Price | Sign up |
| Volume | 41,960,000 |
| Market Cap | $24.9B |
| Year Range | $15.81 - $22.77 |
| Dividend Yield | 0% |
| PE Ratio | 30.17 |
| Analyst Rating | 80% buy |
| Earnings Date | January 29 '25 |
| Industry | Drug Manufacturers |
In the news
 |
Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call TranscriptJanuary 29 - Biztoc.com |
 |
Teva Pharmaceutical Posts Lower Revenue. Stock SlipsJanuary 29 - Biztoc.com |
 |
Teva Pharmaceutical Posts Lower Revenue. Stock Slips.January 29 - Investor's Business Daily |
 |
Geneos Wealth Management Inc. Sells 19,400 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)January 29 - ETF Daily News |
Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA) Price Target Increased by 22.65% to 0.07January 28 - Fintel |
|
|
Teva Pharmaceutical Industries (TEVA) Projected to Post Earnings on WednesdayJanuary 26 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 4.33B | 4.1B | 2.15B | -437M | 208M | 0.690 |
| Q2 '24 | 4.16B | 3.89B | 2.02B | -846M | 254M | 0.610 |
| Q1 '24 | 3.82B | 3.9B | 1.77B | -139M | 54M | 0.480 |
| Q4 '23 | 3.48B | 3.84B | 2.42B | 429M | 988M | 1.000 |
| Q3 '23 | 3.85B | 3.2B | 1.85B | 69M | 638M | 0.600 |
Insider Transactions View All
| MIGNONE ROBERTO filed to sell 695,000 shares at $22. December 26 '24 |
| Fox Christine filed to sell 44,104 shares at $16.9. November 21 '24 |
| Grant Angus filed to sell 8,848 shares at $17.3. August 13 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$151.15 0.5% | 50 |
 |
Eli Lilly and CompanyLLY |
$804.08 0.1% | 66 |
 |
PfizerPFE |
$26.62 0.5% | 38 |
 |
AstrazenecaAZN |
$70.25 0.9% | 49 |
 |
AbbVieABBV |
$175.26 0.3% | 50 |
Read more about Teva Pharmaceutical (TEVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Teva Pharmaceutical?
The Market Cap of Teva Pharmaceutical is $24.9B.
What is Teva Pharmaceutical's PE Ratio?
As of today, Teva Pharmaceutical's PE (Price to Earnings) ratio is 30.17.
When does Teva Pharmaceutical report earnings?
Teva Pharmaceutical will report its next earnings on January 29 '25.
What is the current stock price of Teva Pharmaceutical?
Currently, the price of one share of Teva Pharmaceutical stock is $18.54.
How can I analyze the TEVA stock price chart for investment decisions?
The TEVA stock price chart above provides a comprehensive visual representation of Teva Pharmaceutical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Teva Pharmaceutical shares. Our platform offers an up-to-date TEVA stock price chart, along with technical data analysis and alternative data insights.
Does TEVA offer dividends to its shareholders?
As of our latest update, Teva Pharmaceutical (TEVA) does not offer dividends to its shareholders. Investors interested in Teva Pharmaceutical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Teva Pharmaceutical?
Some of the similar stocks of Teva Pharmaceutical are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.